Compare Howmet Aerospace Inc (HWM) vs GeneDx Holdings Corp (WGS) Price & Performance

Howmet Aerospace (HWM) trades at $271.98, down 0.17% on the day, with technical indicators showing a neutral trend. The company demonstrates strong fundamentals with consistent earnings beats, including Q1 2026 EPS of $1.22 beating expectations of $1.11, and robust profitability with a 20.22% net income margin. Recent news highlights strength in commercial aerospace demand driving growth prospects.

The outlook remains positive with 84% analyst buy ratings and a $317.63 consensus price target implying 17% upside. Key risks include premium valuation multiples and exposure to aerospace cycle volatility. Continued execution on commercial aerospace growth and defense contracts supports the bullish case, though investors should monitor Q2 2026 earnings due August 6 for confirmation.

GeneDx Holdings (WGS) trades at $60.65, down 4.46% today, amid a bearish technical signal and multiple class-action lawsuits alleging securities fraud. The stock shows weak fundamentals with a negative net income margin of -17.58% and ROE of -30.42%, though it beat EPS estimates in two of the last three quarters. Revenue grew to $427.54M in 2025 but profitability remains a challenge, with a high EV/EBITDA of 161.17 indicating stretched valuation relative to earnings.

Despite a 90.9% analyst buy rating and a $75.40 consensus price target, significant risks from litigation and persistent losses cloud the outlook. The stock faces near-term pressure from legal overhangs, while operational cash flow turned negative in 2026. Investors should weigh high analyst optimism against substantial fundamental and legal headwinds before considering a position.